Physician profile
Haoxing Chen
NPI 1205298379
$3,497.31
in general payments reported to CMS, 2019-2025
31 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $77.64 · 2021: $95.70 · 2022: $1,066 · 2023: $1,025 · 2024: $686 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,853.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $757.32 | 2019-2025 | Rocklatan, Clareon, Hydrus Microstent |
| Abbvie INC. | $548.11 | 2022-2024 | Durysta, Xen Glaucoma Treatment System |
| New World Medical,INC. | $398.68 | 2022-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Mallinckrodt Hospital Products INC. | $262.87 | 2022-2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $242.63 | 2022-2025 | Cequa |
| Bausch & Lomb Americas INC. | $157.86 | 2022-2024 | Miebo, Vyzulta, Prolensa |
| Novartis Pharmaceuticals Corporation | $153.44 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $121.23 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $115.00 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $110.85 | 2022-2024 | Tyrvaya |
| Dompe US, INC. | $92.68 | 2021-2025 | Oxervate |
| Biotissue Holdings INC. | $77.53 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $44.28 | 2022 | |
| Amgen INC. | $41.27 | 2024 | Tepezza |
| Rxsight INC | $33.79 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $27.81 | 2024 | Vevye |
| Glaukos Corporation | $27.70 | 2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Horizon Therapeutics Plc | $26.91 | 2023 | Tepezza |
| Ivantis, INC | $26.89 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $25.82 | 2024 | |
| Apellis Pharmaceuticals, INC. | $23.60 | 2023 | Syfovre |
| Sight Sciences, INC. | $23.54 | 2024 | Omni Surgical System |
| Rayner Intraocular Lenses Limited | $23.22 | 2023 | Rayone Spheric, Rayone Aspheric, Omidria |
| Merz North America, INC. | $19.44 | 2020 | |
| Ani Pharmaceuticals, INC. | $18.80 | 2025 | Iluvien |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.31 | 2021 | |
| Oasis Medical, INC. | $17.50 | 2024 | Oasis Tears |
| Eyepoint US, INC. | $16.24 | 2020 | |
| Eyevance Pharmaceuticals LLC | $16.18 | 2022 | |
| Alimera Sciences, INC. | $15.07 | 2020 | |
| Carl Zeiss Meditec Cataract Technology INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haoxing Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.